Efficacy of combined surgery and irradiation for localized Ewings sarcoma family of tumors

被引:48
作者
Krasin, MJ
Rodriguez-Galindo, C
Davidoff, AM
Billups, CA
Fuller, CE
Neel, MD
Kun, LE
Merchant, TE
机构
[1] St Jude Childrens Res Hosp, Dept Radiol Sci, Div Radiat Oncol, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
[3] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA
[4] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA
[5] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA
关键词
Ewings sarcoma; radiation therapy; surgery;
D O I
10.1002/pbc.20095
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Local tumor control for patients with Ewings sarcoma family of tumors (ESFT) is favorable when the primary tumor is resectable or small. Local failure rates for patients who received combined surgery and RT were reviewed to determine outcome and prognostic factors. Procedures. We performed a retrospective review of all patients with localized ESFT treated with combined definitive surgery and RT between 1978 and 2001, at St. Jude Children's Research Hospital. Rates of local failure, survival, and prognostic factors for recurrence were determined in 39 patients who received combined local therapy. Systemic treatment included vincristine, actinomycin D, cyclophosphamide, and doxorubicin (6 patients), with the addition of ifosfamide and etoposide (33 patients). Results. With a median follow-up of 8.7 years the 5- and 8-year survival estimates were 89.2 +/- 5.4% and 82.8 +/- 7.3%. The 8-year incidence of local failure was 10.8 +/- 5.2%. The 8-year local failure rate for patients with positive surgical margins was 17% and for negative surgical margins 5% (P=0.25). Overall survival was improved for patients with negative surgical margins (94 vs. 71%, P=0.052). Tumor size, site, histologic response, and radiation dose did not significantly alter the rate of local failure. Conclusions. Patients with ESFT managed with definitive surgery and irradiation have favorable local control rates. Even among patients with unfavorable prognostic factors local tumor control remained excellent. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:229 / 236
页数:8
相关论文
共 29 条
[1]   EWING SARCOMA - LOCAL TUMOR-CONTROL AND PATTERNS OF FAILURE FOLLOWING LIMITED-VOLUME RADIATION-THERAPY [J].
ARAI, Y ;
KUN, LE ;
BROOKS, MT ;
FAIRCLOUGH, DL ;
FONTANESI, J ;
MEYER, WH ;
HAYES, FA ;
THOMPSON, E ;
RAO, BN .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (06) :1501-1508
[2]  
Carrìe C, 1999, MED PEDIATR ONCOL, V33, P444, DOI 10.1002/(SICI)1096-911X(199911)33:5<444::AID-MPO2>3.0.CO
[3]  
2-D
[4]   Prognostic factors in Ewing's tumor of bone:: Analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study group [J].
Cotterill, SJ ;
Ahrens, S ;
Paulussen, M ;
Jürgens, HF ;
Voûte, PA ;
Gadner, H ;
Craft, AW .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) :3108-3114
[5]   Ifosfamide-containing chemotherapy in Ewing's sarcoma: The second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's tumor study [J].
Craft, A ;
Cotterill, S ;
Malcolm, A ;
Spooner, D ;
Grimer, R ;
Souhami, R ;
Imeson, J ;
Lewis, I .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) :3628-3633
[6]   A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: End results of POG #8346 [J].
Donaldson, SS ;
Torrey, M ;
Link, MP ;
Glicksman, A ;
Gilula, L ;
Laurie, F ;
Manning, J ;
Neff, J ;
Reinus, W ;
Thompson, E ;
Shuster, JJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (01) :125-135
[7]  
DUNST J, 1991, CANCER, V67, P2818, DOI 10.1002/1097-0142(19910601)67:11<2818::AID-CNCR2820671118>3.0.CO
[8]  
2-Y
[9]   RADIATION-THERAPY IN EWINGS-SARCOMA - AN UPDATE OF THE CESS-86 TRIAL [J].
DUNST, J ;
JURGENS, H ;
SAUER, R ;
PAPE, H ;
PAULUSSEN, M ;
WINKELMANN, W ;
RUBE, C .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (04) :919-930
[10]   Five-year results in Ewing's sarcoma.: The Scandinavian Sarcoma Group experience with the SSG IX protocol [J].
Elomaa, I ;
Blomqvist, CP ;
Saeter, G ;
Åkerman, M ;
Stenwig, E ;
Wiebe, T ;
Björk, O ;
Alvegård, TA .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (07) :875-880